1. 130. Meta-Analysis of Tardive Dyskinesia Rates in Randomized Controlled Studies Comparing First- to Second-Generation Antipsychotics. (20th March 2017) Authors: Carbon, Maren; Hsieh, Cheng-Hsi; Kane, John; Correll, Christoph Journal: Schizophrenia bulletin Issue: Volume 43(2017)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose–response study. (August 2015) Authors: Chen, Jing-Xu; Su, Yun-Ai; Bian, Qing-Tao; Wei, Li-He; Zhang, Rong-Zhen; Liu, Yan-Hong; Correll, Christoph; Soares, Jair C.; Yang, Fu-De; Wang, Shao-Li; Zhang, Xiang-Yang Journal: Psychoneuroendocrinology Issue: Volume 58(2015:Aug.) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial. (April 2022) Authors: Schmidt-Kraepelin, Christian; Feyerabend, Sandra; Engelke, Christina; Riesbeck, Mathias; Meisenzahl-Lechner, Eva; Verde, Pablo-Emilio; Correll, Christoph U; Kluge, Michael; Makiol, Christian; Neff, Andrea; Lange, Christina; Englisch, Susanne; Zink, Mathias; Langguth, Berthold; Poeppl, Timm B; Res... Journal: Lancet Issue: Volume 9:Number 4(2022) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association between mental disorders and somatic conditions: protocol for an umbrella review. Issue 4 (8th September 2020) Authors: Cortese, Samuele; Solmi, Marco; Arrondo, Gonzalo; Cipriani, Andrea; Fusar-Poli, Paolo; Larsson, Henrik; Correll, Christoph Journal: Evidence-based mental health Issue: Volume 23:Issue 4(2020) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis. Issue 1 (December 2017) Authors: Correll, Christoph; Ng-Mak, Daisy; Stafkey-Mailey, Dana; Farrelly, Eileen; Rajagopalan, Krithika; Loebel, Antony Journal: Annals of general psychiatry Issue: Volume 16:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Combination of agomelatine and bupropion for treatment‐resistant depression: results from a chart review study including a matched control group. Issue 4 (19th February 2015) Authors: Sühs, Kurt‐Wolfram; Correll, Christoph; Eberlein, Christian K.; Pul, Refik; Frieling, Helge; Bleich, Stefan; Kahl, Kai G. Journal: Brain and behavior Issue: Volume 5:Issue 4(2015:Apr.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus. Issue 3 (21st January 2015) Authors: Kahl, Kai G.; Schweiger, Ulrich; Correll, Christoph; Müller, Conrad; Busch, Marie‐Luise; Bauer, Michael; Schwarz, Peter Journal: Brain and behavior Issue: Volume 5:Issue 3(2015:Mar.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of Lurasidone in Antipsychotic-Naive vs. Antipsychotic-Exposed Adolescents with Schizophrenia: Post-Hoc Analysis of a Two-Year, Open-Label Study. (April 2021) Authors: Correll, Christoph; Tocco, Michael; Pikalov, Andrei; Hsu, Jay; Goldman, Robert Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. F106. EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAïVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY. (9th April 2019) Authors: Correll, Christoph; Goldman, Robert; Tocco, Michael; Pikalov, Andrei; Hsu, Jay; Loebel, Antony Journal: Schizophrenia bulletin Issue: Volume 45(2019)Supplement 2 Page Start: S293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. F46. LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA. (1st April 2018) Authors: Davis, Robert; Dmitrienko, Alex; Glass, Steven; Kozauer, Susan; Saillard, Jelena; Weingart, Michal; Satlin, Andrew; Mates, Sharon; Correll, Christoph; Vanover, Kimberly Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗